PMID: 8956376Nov 1, 1996Paper

Serotonin1b receptor stimulation enhances dopamine-mediated reinforcement

Psychopharmacology
L H ParsonsG F Koob

Abstract

The effect of 5-HT1B receptor stimulation on dopamine-mediated reinforcement in rats was investigated using intravenous self-administration of the selective dopamine uptake inhibitor GBR-12909 on an FR5 schedule of reinforcement. Pretreatment with the 5-HT1A/1B receptor agonist CGS-12066B (1-10 mg/kg, IP) dose-dependently reduced the self-administration of GBR-12909 (83 micrograms/injection) by increasing the interval between drug injections, consistent with a enhancement of the reinforcing effects of GBR-12909. Additionally, CGS-12066B pretreatment (3 mg/kg, IP) shifted the dose-effect function for GBR-12909 self-administration to the left. Pretreatment with the selective 5-HT1A receptor agonist 8-OH-DPAT (0.03-1.0 mg/kg, SC) had no significant effect on GBR-12909 self-administration (83 micrograms/injection), indicating that the effect of CGS-12066B is not mediated by the 5-HT1A receptor. Finally, CGS-12066B pretreatment (1-10 mg/kg, IP) did not alter the self-administration of cocaine (0.03-0.5 mg/injection), suggesting that the simultaneous stimulation of multiple 5-HT receptor subtypes by the indirect 5-HT agonist properties of cocaine may mask the effect of 5-HT1B receptor stimulation on DA-mediated reinforcement.

Citations

Apr 26, 2001·Proceedings of the National Academy of Sciences of the United States of America·I SoraG R Uhl
Dec 28, 2012·Journal of Neural Transmission·Bin Tang, Nachum Dafny
Oct 23, 1998·Annals of Medicine·E M Pich, M P Epping-Jordan
Apr 9, 1999·Nature Neuroscience·S B Caine
Nov 19, 2004·Fundamental & Clinical Pharmacology·Eric DaillyMichel Bourin
Jun 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Helen C FoxRajita Sinha
Oct 8, 2009·European Journal of Clinical Pharmacology·Antonio DragoAlessandro Serretti
Aug 21, 2010·Theoretical Biology & Medical Modelling·Janet BestMichael Reed
Apr 9, 1999·Nature Neuroscience·B A RochaM G Caron
Apr 28, 2004·Neurotoxicity Research·F Weiss, G F Koob
Jul 22, 1999·Annals of the New York Academy of Sciences·K Scearce-LevieR Hen
Mar 22, 2006·Psychopharmacology·R M M De AlmeidaK A Miczek
Jun 9, 2001·Behavioural Pharmacology·E PrzegalinskiJ Siwanowicz
Dec 24, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Robert D RogersCameron S Carter
May 24, 2001·Progress in Neuro-psychopharmacology & Biological Psychiatry·S R Tella, S R Goldberg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atopic Dermatitis

Atopic dermatitis is a chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. Discover the latest research on atopic dermatitis here.